MYD88 and diffuse large B-cell lymphoma: In line with this, in a large study of EBV-related lymphoma, specifically EBV + DLBCL cases were characterized by frequent TET2 and DNMT3A mutations and the paucity of MYD88, CD79B, CDKN2A, and FAS alterations [76].